Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tetravalent dengue VLP vaccine
- Development stage
- Preclinical
- Lead developer
- VLP Therapeutics
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The **tetravalent dengue VLP vaccine** is a non-replicating virus-like particle (VLP)-based vaccine candidate designed to protect against all four dengue virus serotypes (DENV1-4). Developed by **VLP Therapeutics** using their proprietary VLP platform, it presents equal quantities of structural antigens (prM and E proteins) from each serotype to induce balanced, high-titer neutralizing antibodies without antibody-dependent enhancement (ADE), a key safety concern for dengue vaccines. Preclinical studies in non-human primates demonstrated robust humoral immunity, reduced viral replication upon challenge, and protection via IgG transfer in mice; it shows promise for safe use in immunocompromised individuals and is advancing toward clinical evaluation for dengue prevention.[2][4][6]
- Other names
- DENVLP vaccine
02
Targets
DENV (Flavivirus antigens and proteins)
Beyond the preview
Go deeper on tetravalent dengue VLP vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tetravalent dengue VLP vaccine.